serine protease inhibitors (SuperGen/Wichita)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameserine protease inhibitors (SuperGen/Wichita)
Drug Alias Nameserine protease inhibitors (Sparta)serine protease inhibitors (Sparta/Wichita)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine protease inhibitors
TargetsSerine protease
Therapy Area/IndicationsInflammationEmphysemaPsoriasis +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWichita State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWichita State UniversitySparta Pharmaceuticals IncAstex Pharmaceuticals Inc +[4] 
Active IndicationsN/A
Inactive IndicationsInflammationEmphysemaPsoriasis +[8] 

Other Information

ATC CodeN/A
Related LinksN/A